Fonarow Gregg C, Heywood J Thomas, Heidenreich Paul A, Lopatin Margarita, Yancy Clyde W
Ahmanson-UCLA Cardiomyopathy Center, Los Angeles, CA 90095, USA.
Am Heart J. 2007 Jun;153(6):1021-8. doi: 10.1016/j.ahj.2007.03.012.
The purpose of this study was to assess temporal trends in clinical characteristics, treatments, quality indicators, and outcomes for heart failure (HF) hospitalizations.
Characteristics, treatments, quality measures, and inhospital outcomes were measured over 12 consecutive quarters (January 2002 to December 2004) using data from 159,168 enrollments from 285 ADHERE hospitals.
Baseline characteristics were similar or showed only modest changes, and severity of illness by logistic regression was unchanged over all 12 quarters. Inhospital treatment changed significantly over time with inotrope use decreasing from 14.7% to 7.9% (P < .0001). Discharge instructions increased 133%; smoking counseling, 132%; left ventricular function measurement, 8%; and beta-blocker use, 29% (all P < .0001). Clinical outcomes improved over time, including need for mechanical ventilation, which decreased 5.3% to 3.4% (relative risk 0.64, P < .0001); length of stay (mean), 6.3 to 5.5 days; and mortality, 4.5% to 3.2% (relative risk 0.71, P < .0001).
Over a 3-year period, demographics and clinical characteristics were relatively similar, but significant changes in intravenous therapy, enhancements in conformity to quality-of-care measures, increased administration of evidence-based HF medications, and substantial improvements in inhospital morbidity and mortality were observed during hospitalization for HF.
本研究旨在评估心力衰竭(HF)住院患者的临床特征、治疗方法、质量指标及预后的时间趋势。
利用285家ADHERE医院159,168例登记患者的数据,对连续12个季度(2002年1月至2004年12月)的特征、治疗、质量指标及住院结局进行测量。
基线特征相似或仅有轻微变化,通过逻辑回归分析得出的疾病严重程度在全部12个季度中无变化。住院治疗随时间发生显著变化,血管活性药物的使用从14.7%降至7.9%(P < 0.0001)。出院指导增加了133%;吸烟咨询增加了132%;左心室功能测量增加了8%;β受体阻滞剂的使用增加了29%(均P < 0.0001)。临床结局随时间得到改善,包括机械通气需求从5.3%降至3.4%(相对风险0.64,P < 0.0001);住院时间(均值)从6.3天降至5.5天;死亡率从4.5%降至3.2%(相对风险0.71,P < 0.0001)。
在3年期间,人口统计学和临床特征相对相似,但在心力衰竭住院期间,观察到静脉治疗有显著变化、符合医疗质量指标的情况有所改善、循证性心力衰竭药物的使用增加以及住院发病率和死亡率大幅下降。